Literature DB >> 8344334

Factors affecting the assay of urinary 3-hydroxy pyridinium crosslinks of collagen as markers of bone resorption.

A Colwell1, R G Russell, R Eastell.   

Abstract

The measurement of the 3-OH pyridinium compounds, pyridinoline (Pyr) and deoxypyridinoline (Dpyr), in urine by high performance liquid chromatography is potentially useful in clinical studies, since they are specific biochemical markers of bone resorption. The aims of the present study were to improve assay performance and optimize sample collection. An isocratic high performance liquid chromatogram (HPLC) separation with baseline resolution was accomplished within 4 min using heptafluorobutyric acid as an ion-pair. The sample preparation for HPLC, using CF1 cellulose, produced uncontaminated samples with a recovery higher than 90% for both crosslinks. An elastin-derived material, tentatively identified as isodesmosine (Ides), was also tested and proved to be a suitable internal standard. Use of this standard improved assay precision. The effect of an oral gelatin load on the excretion of Pyr and Dyr was investigated. The creatinine corrected excretion of Pyr and Dpyr was unchanged over a 6 h period, in contrast to the 10-fold increase in the excretion of urinary hydroxyproline with a peak 2-4 h after ingestion. In 20 postmenopausal women, 2 h fasting morning urine results correlated with results from 24-h urine collections Dpyr/Cr (r = 0.70, n = 20). There was a day-to-day variation of 26% in adults studied for 10 days.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8344334     DOI: 10.1111/j.1365-2362.1993.tb02034.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  17 in total

Review 1.  Bone turnover markers: use in osteoporosis.

Authors:  Kim Naylor; Richard Eastell
Journal:  Nat Rev Rheumatol       Date:  2012-06-05       Impact factor: 20.543

Review 2.  Diagnostic biomarkers for oral and periodontal diseases.

Authors:  Mario Taba; Janet Kinney; Amy S Kim; William V Giannobile
Journal:  Dent Clin North Am       Date:  2005-07

3.  Biochemical markers of bone turnover: part I: biochemistry and variability.

Authors:  Markus J Seibel
Journal:  Clin Biochem Rev       Date:  2005-11

4.  Quantitative analysis of pyridinium crosslinks of collagen in the synovial fluid of patients with rheumatoid arthritis using high-performance liquid chromatography.

Authors:  A Müller; G Hein; S Franke; D Herrmann; S Henzgen; A Roth; G Stein
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

5.  The determination of pyridinium crosslinks in urine and serum as a possible marker of cartilage degradation in rheumatoid arthritis.

Authors:  G Hein; S Franke; A Müller; E Bräunig; T Eidner; G Stein
Journal:  Clin Rheumatol       Date:  1997-03       Impact factor: 2.980

6.  An assessment of genetic markers as predictors of bone turnover in healthy adults.

Authors:  D Sheehan; T Bennett; K D Cashman
Journal:  J Endocrinol Invest       Date:  2001-04       Impact factor: 4.256

7.  Phytoestrogen-rich herb formula "XLGB" prevents OVX-induced deterioration of musculoskeletal tissues at the hip in old rats.

Authors:  Ling Qin; Ge Zhang; Wing-Yin Hung; Yinyu Shi; Kwoksui Leung; Hiu-Yan Yeung; Pingchung Leung
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

8.  Combining bone resorption markers and heel quantitative ultrasound to discriminate between fracture cases and controls.

Authors:  D Nanchen; J Cornuz; C Ruffieux; W Riesen; P Burckhardt; M A Krieg
Journal:  Osteoporos Int       Date:  2009-01-31       Impact factor: 4.507

9.  [Biochemical bone resorption markers during the healing of osteoporotic fractures].

Authors:  C Heiss; L M Hoesel; M Pausch; S A Meissner; U Horas; O Kilian; U Wehr; W A Rambeck; R Schnettler
Journal:  Unfallchirurg       Date:  2008-09       Impact factor: 1.000

10.  Urinary free deoxypyridinoline levels during childhood.

Authors:  A Conti; S Ferrero; S Giambona; A Sartorio
Journal:  J Endocrinol Invest       Date:  1998-05       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.